Hepatocytes provide a defined system for the study of hepatic drug metabolism and the prediction of liver toxicity due to xenobiotics. A major problem associated with the use of hepatocytes is the limited useful lifetime of the preparations. Effective storage techniques would be particularly useful when applied to human liver cells as the availability of suitable tissue is limited. The effect of freezing for short periods (at -8OoC) on the viability of hepatocytes and on xenobiotic metabolism was investigated. Previous attempts to cryopreserve hepatocytes indicated that dimethylsulphoxide (DMSO) was the most suitable cryoprotectant available (Novicki e t al, 1982; Fuller e t al, 1980). Sprague-Dawley rat hepatocytes (viability > 85%) were prepared as described by Moldeus e t al. (1 978). They were frozen in Eppendorf tubes ( 5 x 106cells/ml) in differing proportions of Liebowitz's LI 5 medium, foetal calf serum (FCS) and DMSO in order to identify optimum freezing conditions. The cells were held at 0°C for 15 min to equilibAbbreviations used: DMSO, dimethylsulphoxide; FCS, foetal calf serum; GSH, reduced glutathione; CDNB, I -chloro-2,4-dinitrobenzene; BSA, bovine serum albumin. rate with the cryoprotectant medium, then cooled at I"C/ min to -80°C. After storage they were thawed rapidly at 3 7 T , washed once with LI 5 medium, then once with KrebsHenseleit buffer, pH 7.4, containing 10 mM-Hepes. They were finally resuspended in the same buffer at 10 x 10' cells/ml before viability and metabolism studies were carried out. Viability was determined by Trypan Blue exclusion and the indices of metabolism measured were cytochrome P-450
(1 978). They were frozen in Eppendorf tubes ( 5 x 106cells/ml) in differing proportions of Liebowitz's LI 5 medium, foetal calf serum (FCS) and DMSO in order to identify optimum freezing conditions. The cells were held at 0°C for 15 min to equilibAbbreviations used: DMSO, dimethylsulphoxide; FCS, foetal calf serum; GSH, reduced glutathione; CDNB, I -chloro-2,4-dinitrobenzene; BSA, bovine serum albumin. rate with the cryoprotectant medium, then cooled at I"C/ min to -80°C. After storage they were thawed rapidly at 3 7 T , washed once with LI 5 medium, then once with KrebsHenseleit buffer, pH 7.4, containing 10 mM-Hepes. They were finally resuspended in the same buffer at 10 x 10' cells/ml before viability and metabolism studies were carried out. Viability was determined by Trypan Blue exclusion and the indices of metabolism measured were cytochrome P-450 content (Omura & Sato, 1964 ; Grant e t al, 1985), the activity of P-450-dependent N-demethylation of 20 mMaminopyrine, reduced glutathione (GSH) content (Saville, 1958) and GSH conjugation of 50 PM-1 -chloro-2,4-dinitrobenzene (CDNB). All the results are expressed as a percentage of the initial fresh cell values. Fresh cell viability was 87 2% (n = lo), P-450 content was 0.44 f 0.04 nmol/ 10' cells ( n = 10) and GSH content was 27.7 & 3 nmol/lOh viable cells ( n = 10). GSH is rapidly lost through damaged cell membranes so its concentration was calculated in terms of the number of viable cells.
The DMSO content of the cryoprotectant medium was optimized by varying the composition from 10 to 30% (v/v) DMSO, with the FCS concentration constant at 25% (v/v). Fig. l ( a ) shows that the DMSO content was optimal at 20% (v/v) for maintenance of viability, P-450 and GSH. The 616th MEETING, LONDON 30% (v/v). In subsequent experiments 25% (v/v) was used. At this concentration viability was 58 f 4%, P-450 content was 86 f 6% and GSH was 58
In order to define chemically the cryoprotectant medium the effect of substituting bovine serum albumin (BSA) for FCS was investigated by comparing IMo/~ (w/v) BSA with 25% (v/v) FCS. In these experiments the viability after 24 h in 4% (w/v) BSA-containing medium was 45%, the P-450 content was 76% and GSH content was 54% compared with 61%, 86% and 67% respectively in 25% (v/v) FCS.
Using the optimal conditions of 20% (v/v) DMSO, 25% (v/v) FCS and 55% (v/v) L15 medium, GSH conjugation and P-450-dependent N-demethylation were measured after 24 and 48h storage (Fig. Ih) . Although the viability of the cells after freezing was decreased, the P-450 and GSH content and their dependent reactions were well maintained for 24 h indicating that the above conditions are suitable for short-term storage of hepatocytes.
These conditions were then applied to the study of viability and P-450 content of human adult hepatocytes after freezing at -8 0°C for periods of 24,48 and 72 h. The same DMSO content was found to be optimal for storage of human hepatocytes and the viability and P-450 content at 6% after 24h storage. 24 h were 59% and 51 % respectively, at 48 h 48% and 55% respectively and at 72 h 48% and 5 1' / 0 respectively.
In conclusion, rat hepatocytescan be frozen at -80 C for 24-48 h with maintenance of xenobiotic-metabolizing activities. Application of similar preservation conditions to human hepatocytes has yielded promising results and further improvement may be achieved in future by the additive cryoprotection of DMSO and polyethylene glycol 3500.
The majority of the screening for new anti-cancer agents has employed in vivo transplantable tumours (Venditti et ul., 1984) . These can be both expensive and time-consuming. Cell culture screening systems have been used, providing a more rapid and economic alternative. However, one of the major problems with the use of cell culture systems in vitro, is the inability of cells in vitro to carry out many of the metabolic activation/deactivation reactions performed in vivo (Kraemer & Sedlacek, 1984) . The aim of this work is to demonstrate the use of a rat-liver-derived metabolizing system (S9 fraction) in conjuction with a cytotoxicity assay in vitro as a screen for anti-cancer agents.
The test compound used was cyclophosphamide, an anticancer agent which requires metabolic activation (Bender et ul., 1978) . The need for metabolic activation can be demonstrated by the differential inhibitory effect of cyclophosphamide, a metabolite analogue hydroperoxycyclophosphamide, and the active metabolite phosphoramide mustard on the DNA synthesis of Epstein-Barr virus-transformed lymphoblasts. DNA synthesis was measured by the incorporation of ['Hlthymidine into cold acid-precipitable material over a 1 h incubation period as previously described (Fricker & Swoboda, 1982) . At 5 mM, cyclophosphamide gave only 20% inhibition, whereas hydroperoxycyclophosphamide and phosphoramide mustard gave 90% and 60% inhibition of thymidine incorporation respectively.
HeLa cells, a cell derived from a human cervical carcinoma, were chosen as a suitable model system in vitro. Control experiments have shown that total cell protein can be used as a measure of cell growth. HeLa cells, 5ml at 5 x 104/ml, were cultured in plastic Petri dishes (60mm x 15mm) for a total of l00h. Cultures were harvested at regular intervals and the cells removed by gentle trypsinization, and washed with Dulbecco's phosphate-buffered saline. Protein was precipitated with 5% trichloroacetic acid and the precipitate redissolved in 0.1 MNaOH and total cell protein determined. Cell protein Vol. 14 increased linearly with time (10 ng/h) until the cultures reached confluency at 94 h. We have used total cell protein as a parameter for demonstrating the cytotoxic effect of the anti-tumour agent cisplatin (Fig. I) . Cisplatin does not require metabolic activation and is 100% cytotoxic at 0.1 mM. Fig. 1 . Assuy of unti-tumour agent cytoto.uicity with und without u metuholizing system HeLa cells, 5ml at 5 x 104cells/ml, were incubated in MEM (Eagles) medium, 37 C, 5% CO,, on plastic petri dishes for 24 h. The medium was removed and the cultures treated for 2 h with the test compound with or without the metabolizing system. The drug was washed off, the medium replaced and the cultures incubated for a further 72 h. The cells were harvested and total cell protein assayed using the Lowry method modified for an autoanalyser. A. Cyclophosphamide; B, cyclophosphamide + S9; C. cisplatin.
